|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.60 EUR | -0.37% |
|
+5.55% | +55.68% |
| 09/07 | Orion raises outlook for 2025 | RE |
| 09/07 | Orion Upgrades FY25 Net Sales, Operating Profit Outlook | MT |
| Capitalization | 935.73Cr 1.09TCr 871.6Cr 810.67Cr 1.5TCr 94TCr 1.66TCr 10TCr 3.99TCr 44TCr 4.1TCr 4.02TCr 1,61300Cr | P/E ratio 2025 * |
25.6x | P/E ratio 2026 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise value | 940.14Cr 1.1TCr 875.71Cr 814.49Cr 1.5TCr 94TCr 1.67TCr 10TCr 4.01TCr 44TCr 4.12TCr 4.04TCr 1,62000Cr | EV / Sales 2025 * |
5.6x | EV / Sales 2026 * | 4.66x |
| Free-Float |
89.32% | Yield 2025 * |
2.58% | Yield 2026 * | 2.78% |
More valuation ratios
* Estimated data
More news
Last Transcript: Orion Oyj
More recommendations
More press releases
More news
| 1 day | -0.37% | ||
| 1 week | +5.55% | ||
| Current month | +4.31% | ||
| 1 month | +4.06% | ||
| 3 months | +38.92% | ||
| 6 months | +47.57% | ||
| Current year | +55.68% |
| 1 week | 62.7 |  | 67.7 |
| 1 month | 61.7 | | 67.7 |
| Current year | 42.8 | | 67.7 |
| 1 year | 39.39 | | 67.7 |
| 3 years | 31.86 | | 67.7 |
| 5 years | 31.86 | | 67.7 |
| 10 years | 22.57 | | 67.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 01/11/2022 | |
René Lindell
DFI | Director of Finance/CFO | 49 | 01/05/2024 |
| Chief Operating Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Eija Ronkainen
BRD | Director/Board Member | 59 | 22/03/2016 |
| Director/Board Member | 62 | 22/03/2017 | |
Hilpi Rautelin
BRD | Director/Board Member | 64 | 22/03/2017 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 2.96% | 806 M€ | +8.43% | - | |
| 2.87% | 478 M€ | +15.60% | - | |
| 0.52% | 0 M€ | -.--% | - | |
| 0.35% | 1,022 M€ | +19.74% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.37% | +5.55% | +61.96% | +50.47% | 1.09TCr | ||
| +0.30% | +1.58% | -16.38% | +145.07% | 71TCr | ||
| -0.50% | +0.57% | +4.68% | -10.78% | 38TCr | ||
| -1.31% | +1.67% | +13.02% | +26.23% | 34TCr | ||
| -3.64% | -2.74% | -55.22% | +8.38% | 31TCr | ||
| -2.36% | -1.23% | +0.78% | -21.80% | 26TCr | ||
| -3.00% | -1.93% | -3.83% | +16.05% | 24TCr | ||
| -1.66% | +1.10% | -14.76% | -6.40% | 22TCr | ||
| -0.79% | +3.00% | -34.75% | -10.94% | 21TCr | ||
| -1.70% | -1.00% | -10.75% | +19.56% | 16TCr | ||
| Average | -1.50% | +1.05% | -5.52% | +21.58% | 28.28TCr | |
| Weighted average by Cap. | -1.29% | +0.66% | -12.22% | +38.48% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 167.8Cr 196.23Cr 156.3Cr 145.37Cr 268.61Cr 17TCr 298.51Cr 1.87TCr 716.05Cr 7.88TCr 735.97Cr 720.8Cr 29TCr | 197.49Cr 230.96Cr 183.96Cr 171.1Cr 316.14Cr 20TCr 351.33Cr 2.2TCr 842.76Cr 9.28TCr 866.2Cr 848.34Cr 34TCr |
| Net income | 37Cr 43Cr 34Cr 32Cr 59Cr 3.68TCr 65Cr 409.05Cr 156.4Cr 1.72TCr 160.75Cr 157.43Cr 6.32TCr | 53Cr 62Cr 50Cr 46Cr 85Cr 5.36TCr 95Cr 595.86Cr 227.82Cr 2.51TCr 234.16Cr 229.33Cr 9.2TCr |
| Net Debt | 4.41Cr 5.16Cr 4.11Cr 3.82Cr 7.06Cr 442.61Cr 7.85Cr 49Cr 19Cr 207.24Cr 19Cr 19Cr 760.15Cr | -14Cr -17Cr -13Cr -13Cr -23Cr -1.45TCr -26Cr -161.51Cr -62Cr -679.85Cr -63Cr -62Cr -2.49TCr |
More financial data
* Estimated data
Employees
3,943
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/25/11 | 66.60 € | -0.37% | 1,33,967 |
| 10/25/10 | 66.85 € | +1.83% | 2,21,243 |
| 09/25/09 | 65.65 € | 0.00% | 3,93,891 |
| 08/25/08 | 65.65 € | +3.55% | 3,07,083 |
| 07/25/07 | 63.40 € | +0.48% | 1,49,917 |
Delayed Quote Nasdaq Helsinki, July 11, 2025 at 09:30 pm IST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
66.60EUR
Average target price
58.50EUR
Spread / Average Target
-12.16%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ORNBV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition